Uveitis Recruiting Phase 3 Trials for Adalimumab (DB00051)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04798755Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior UveitisTreatment